Marked Decrease in CA 19-9 Level Belies Rapidly Progressive Lymphangitic Carcinomatosis in a Case of Metastatic Pancreatic Cancer
Background: The CA 19-9 tumor marker is commonly used alongside imaging to trend chemotherapy response in patients with pancreatic ductal adenocarcinoma. Presentation: We describe an unusual clinical case of metastatic pancreatic cancer who achieved a marked decline in CA 19-9 but paradoxically deve...
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Mary Ann Liebert
2020-11-01
|
| Series: | Journal of Pancreatic Cancer |
| Online Access: | https://www.liebertpub.com/doi/full/10.1089/PANCAN.2020.0015 |